Pregnancy in pulmonary arterial hypertension (RCD code: VII‑II‑1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2016, Vol 2, Issue 7
Abstract
Pulmonary arterial hypertension (PAH) is a progressive disease leading to right ventricular failure and death, if not treated adequately. Pregnancy in women with PAH is associated with significantly high mortality, thus current guidelines strongly recommend, that pregnancy in PAH female patients should be avoided and in the case of pregnancy, termination at early stage is recommended. We present results of a study aimed at assesing maternal and newborn outcomes in gravidas with PAH. Five pregnant females with PAH in the mean age of 29.6 ±8.23 years were included in the study. In two patients idiopathic PAH (IPAH) and in three PAH due to congenital heart defects and Eisenmenger syndrome were diagnosed. Three patients received PAH-specific therapy (monotherapy) prior to pregnancy. During pregnancy two women received sildenafil, then treprostinil (one started in 33rd week of gestation, second few hours before labour). Two patients did not received PAH specific therapy due to non-availability in Poland at that time and one according to treatment denial. In one case spontaneous abortion at the 8th week of pregnancy occurred and one of the patients reported 4 previous miscarriages. Two patients are still alive, one is lost to follow-up and two of them died: one in the postpartum period and the second ca. 18 month after abortion. All newborns survived.Considering the high mortality rate among pregnant women with PAH, pregnancy is strongly contraindicated. If the patient decides to continue pregnancy she should be under medical care in a specialist centre with a multidisciplinary approach and PAH specific treatment should be administered.
Authors and Affiliations
Magdalena Kaźnica-Wiatr, Agata Leśniak-Sobelga, Grzegorz Kopeć, Piotr Błaszczak, Karolina Frynas, Maria Olszowska, Krzysztof Rytlewski, Jarosław Kasprzak
Keywords
Related Articles
- EP ID EP245347
- DOI 10.20418/jrcd.vol2no7.235
- Views 90
- Downloads 0
The atrial septal defect diagnosed in the senility – the benefit of the transcatheter closure (RCD code: IV‑2B.1)
Objective: Closure of the atrial septal defect in the elderly patients is controversial. The aim of the study was to evaluate the outcomes of transcatheter closure of secundum atrial septal defect (ASD) in elderly patien...
The pilot study of role of electrical cardiometry in non‑invasive assessment of hemodynamic parameters in patients with pulmonary arterial hypertension (RCD code: II‑1A.1)
Background: Electrical cardiometry (EC) technique could estimate cardiac output (CO), cardiac index (CI) and other parameters related to cardiac contractility and fluid status by measuring the thoracic electrical bioimpe...
Report from the 65th American College of Cardiology Congress 2016 in Chicago, USA
Having visited several European Society of Cardiology (ESC) Congresses, this time the plan was to explore famous American College of Cardiology (ACC) annual Congress. For a long time American way of making science domina...
62 year‐old woman with recurrent pleural and pericardial effusion (RCD code: III)
The spectrum of pericardial diseases consists of congenital defects, pericarditis (dry, effusive, effusive-constrictive, and constrictive), neoplasm, and cysts. The aetiological classification comprises: infectious peric...
4th Symposium on Rare Cardiovascular Diseases – ESC Barcelona 2014
Raport from the Satellite Symposium on Rare Cardiovascular Diseases.